Work

Abituzumab (Di17E6, Emd 525797) Treatment for Chemotherapy-Naive Patients with Asymptomatic or Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Primary Outcomes of the Placebo-Controlled Phase 2 Study Perseus (Nct01360840)

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu336.20

Authors: K. Miller, M. Hussain, S. Le Moulec, I. Rybicka, R. Bruns, J. Straub

Institutions: Stiftung Charité, Charité - Universitätsmedizin Berlin, University of Michigan, Michigan Center for Translational Pathology, U-M Rogel Cancer Center, HIA du Val-de-Grâce à Paris, Merck KGaA, Darmstadt (Germany)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2279620155

FWCI:

Cites:

Cited by:

Related to: 10